vs
Side-by-side financial comparison of Mama's Creations, Inc. (MAMA) and Phathom Pharmaceuticals, Inc. (PHAT). Click either name above to swap in a different company.
Phathom Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($57.6M vs $47.3M, roughly 1.2× Mama's Creations, Inc.). On growth, Phathom Pharmaceuticals, Inc. posted the faster year-over-year revenue change (94.1% vs 50.0%). Mama's Creations, Inc. produced more free cash flow last quarter ($3.7M vs $-167.0M).
Mama's Creations, Inc. is a U.S.-based food manufacturing enterprise that produces a wide portfolio of refrigerated ready-to-eat and heat-and-serve food products, including Italian-style meatballs, sausages, pasta dishes, and other prepared meals. It mainly distributes its offerings to grocery retailers, mass merchandisers and foodservice partners across the United States, focusing on convenient, high-quality comfort food for daily consumer demand.
Phathom Pharmaceuticals is a clinical-stage biopharmaceutical firm focused on developing and commercializing innovative therapies for gastrointestinal diseases. Its lead product candidates address acid-related disorders, inflammatory bowel disease, and other GI conditions, serving patients mainly across North America and Europe.
MAMA vs PHAT — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.3M | $57.6M |
| Net Profit | $540.0K | — |
| Gross Margin | 23.6% | 86.7% |
| Operating Margin | 1.7% | — |
| Net Margin | 1.1% | — |
| Revenue YoY | 50.0% | 94.1% |
| Net Profit YoY | 31.7% | 71.6% |
| EPS (diluted) | $0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.3M | $57.6M | ||
| Q3 25 | $35.2M | $49.5M | ||
| Q2 25 | $35.3M | $39.5M | ||
| Q1 25 | $33.6M | $28.5M | ||
| Q4 24 | $31.5M | $29.7M | ||
| Q3 24 | $28.4M | $16.4M | ||
| Q2 24 | $29.8M | $7.3M | ||
| Q1 24 | $26.7M | — |
| Q4 25 | $540.0K | — | ||
| Q3 25 | $1.3M | $-30.0M | ||
| Q2 25 | $1.2M | $-75.8M | ||
| Q1 25 | $1.6M | $-94.3M | ||
| Q4 24 | $410.0K | — | ||
| Q3 24 | $1.1M | $-85.6M | ||
| Q2 24 | $553.0K | $-91.4M | ||
| Q1 24 | $1.4M | — |
| Q4 25 | 23.6% | 86.7% | ||
| Q3 25 | 24.9% | 87.5% | ||
| Q2 25 | 26.1% | 87.2% | ||
| Q1 25 | 27.0% | 86.9% | ||
| Q4 24 | 22.6% | 87.1% | ||
| Q3 24 | 24.2% | 85.6% | ||
| Q2 24 | 25.0% | 81.2% | ||
| Q1 24 | 29.3% | — |
| Q4 25 | 1.7% | — | ||
| Q3 25 | 4.8% | -30.8% | ||
| Q2 25 | 4.5% | -151.7% | ||
| Q1 25 | 5.7% | -276.5% | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 5.7% | -433.0% | ||
| Q2 24 | 2.6% | -1055.4% | ||
| Q1 24 | 7.4% | — |
| Q4 25 | 1.1% | — | ||
| Q3 25 | 3.6% | -60.5% | ||
| Q2 25 | 3.5% | -191.9% | ||
| Q1 25 | 4.8% | -330.7% | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 4.0% | -523.3% | ||
| Q2 24 | 1.9% | -1248.6% | ||
| Q1 24 | 5.3% | — |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.03 | $-0.41 | ||
| Q2 25 | $0.03 | $-1.05 | ||
| Q1 25 | $0.04 | $-1.31 | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $0.03 | $-1.32 | ||
| Q2 24 | $0.01 | $-1.56 | ||
| Q1 24 | $0.03 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.1M | $130.0M |
| Total DebtLower is stronger | — | $209.1M |
| Stockholders' EquityBook value | $49.6M | $-438.2M |
| Total Assets | $84.0M | $259.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.1M | $130.0M | ||
| Q3 25 | $9.4M | $135.2M | ||
| Q2 25 | $12.0M | $149.6M | ||
| Q1 25 | $7.2M | $212.3M | ||
| Q4 24 | $9.3M | $297.3M | ||
| Q3 24 | $7.4M | $334.7M | ||
| Q2 24 | $13.0M | $276.2M | ||
| Q1 24 | $11.0M | — |
| Q4 25 | — | $209.1M | ||
| Q3 25 | — | $207.1M | ||
| Q2 25 | — | $205.1M | ||
| Q1 25 | — | $203.2M | ||
| Q4 24 | — | $201.4M | ||
| Q3 24 | — | $175.7M | ||
| Q2 24 | — | $174.4M | ||
| Q1 24 | — | — |
| Q4 25 | $49.6M | $-438.2M | ||
| Q3 25 | $29.6M | $-422.5M | ||
| Q2 25 | $26.4M | $-405.8M | ||
| Q1 25 | $24.9M | $-338.4M | ||
| Q4 24 | $23.0M | $-253.6M | ||
| Q3 24 | $22.3M | $-187.1M | ||
| Q2 24 | $20.3M | $-233.8M | ||
| Q1 24 | $19.6M | — |
| Q4 25 | $84.0M | $259.1M | ||
| Q3 25 | $51.2M | $240.3M | ||
| Q2 25 | $52.7M | $250.2M | ||
| Q1 25 | $47.1M | $294.2M | ||
| Q4 24 | $47.9M | $378.3M | ||
| Q3 24 | $43.0M | $387.0M | ||
| Q2 24 | $47.2M | $319.4M | ||
| Q1 24 | $45.1M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.9M | $-166.8M |
| Free Cash FlowOCF − Capex | $3.7M | $-167.0M |
| FCF MarginFCF / Revenue | 7.8% | -290.0% |
| Capex IntensityCapex / Revenue | 0.4% | 0.4% |
| Cash ConversionOCF / Net Profit | 7.16× | — |
| TTM Free Cash FlowTrailing 4 quarters | $6.0M | $-328.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.9M | $-166.8M | ||
| Q3 25 | $-1.7M | $-14.1M | ||
| Q2 25 | $6.0M | $-62.7M | ||
| Q1 25 | $-857.0K | $-84.9M | ||
| Q4 24 | $4.8M | $-266.8M | ||
| Q3 24 | $-2.4M | $-63.6M | ||
| Q2 24 | $3.6M | $-70.7M | ||
| Q1 24 | $6.7M | — |
| Q4 25 | $3.7M | $-167.0M | ||
| Q3 25 | $-2.2M | $-14.1M | ||
| Q2 25 | $5.5M | $-62.8M | ||
| Q1 25 | $-930.0K | $-84.9M | ||
| Q4 24 | $2.5M | $-266.9M | ||
| Q3 24 | $-4.0M | $-63.6M | ||
| Q2 24 | $2.5M | $-70.8M | ||
| Q1 24 | $6.6M | — |
| Q4 25 | 7.8% | -290.0% | ||
| Q3 25 | -6.2% | -28.6% | ||
| Q2 25 | 15.5% | -159.0% | ||
| Q1 25 | -2.8% | -297.9% | ||
| Q4 24 | 8.0% | -899.8% | ||
| Q3 24 | -14.1% | -389.0% | ||
| Q2 24 | 8.4% | -966.2% | ||
| Q1 24 | 24.8% | — |
| Q4 25 | 0.4% | 0.4% | ||
| Q3 25 | 1.5% | 0.1% | ||
| Q2 25 | 1.5% | 0.2% | ||
| Q1 25 | 0.2% | 0.1% | ||
| Q4 24 | 7.2% | 0.5% | ||
| Q3 24 | 5.6% | 0.3% | ||
| Q2 24 | 3.8% | 0.6% | ||
| Q1 24 | 0.4% | — |
| Q4 25 | 7.16× | — | ||
| Q3 25 | -1.31× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | -0.54× | — | ||
| Q4 24 | 11.71× | — | ||
| Q3 24 | -2.10× | — | ||
| Q2 24 | 6.58× | — | ||
| Q1 24 | 4.79× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
